Unresectable NUT Carcinoma

4 clinical trials · Condition

Record	Firm	Date
Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma (NCT07050186)	Northwestern University	2025-08-15
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors (NCT05372640)	National Cancer Institute (NCI)	2023-08-10
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma (NCT05019716)	National Cancer Institute (NCI)	2022-07-13
Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma (NCT04116359)	National Cancer Institute (NCI)	2020-09-18

Every clearance here is in the API, with alerts when new ones post.